Works by Park, Se-Hoon

Results: 110
    1
    2

    Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04019-x
    By:
    • Porta, Camillo;
    • Massari, Francesco;
    • Taha, Tarek;
    • Grande, Enrique;
    • Bourlon, Maria T.;
    • Kanesvaran, Ravindran;
    • Basso, Umberto;
    • Molina-Cerrillo, Javier;
    • Alonso-Gordoa, Teresa;
    • Myint, Zin W.;
    • Fornarini, Giuseppe;
    • Buttner, Thomas;
    • Park, Se Hoon;
    • Ürün, Yüksel;
    • De Giorgi, Ugo;
    • Pichler, Renate;
    • Rescigno, Pasquale;
    • Buchler, Tomas;
    • Studentova, Hana;
    • Melichar, Bohuslav
    Publication type:
    Article
    3
    4
    5

    Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1141, doi. 10.1007/s00280-008-0839-y
    By:
    • Seong Yoon Yi;
    • Park, Young Suk;
    • Hyo Song Kim;
    • Hyun Jung Jun;
    • Kyoung Ha Kim;
    • Myung Hee Chang;
    • Park, Min Jae;
    • Ji Eun Uhm;
    • Jeeyun Lee;
    • Park, Se Hoon;
    • Park, Joon Oh;
    • Jong Kyun Lee;
    • Kyu Taek Lee;
    • Ho Yeong Lim;
    • Won Ki Kang
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma.

    Published in:
    Cancers, 2022, v. 14, n. 10, p. 2354, doi. 10.3390/cancers14102354
    By:
    • Jee, ByulA;
    • Seo, Eunjeong;
    • Park, Kyunghee;
    • Kim, Yi Rang;
    • Byeon, Sun-ju;
    • Lee, Sang Min;
    • Chung, Jae Hoon;
    • Song, Wan;
    • Sung, Hyun Hwan;
    • Jeon, Hwang Gyun;
    • Jeong, Byong Chang;
    • Seo, Seong Il;
    • Jeon, Seong Soo;
    • Lee, Hyun Moo;
    • Park, Se Hoon;
    • Park, Woong-Yang;
    • Kang, Minyong
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 1, p. 183, doi. 10.1007/s10637-012-9853-3
    By:
    • Hong, Yong Sang;
    • Lee, Jeeyun;
    • Kim, Kyu-pyo;
    • Lee, Jae-Lyun;
    • Park, Young Suk;
    • Park, Joon Oh;
    • Park, Se Hoon;
    • Kim, Sun Young;
    • Baek, Ji Yeon;
    • Kim, Jee Hyun;
    • Lee, Keun-Wook;
    • Kim, Tae-You;
    • Kim, Tae Won
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Comprehensive pharmacogenomic characterization of gastric cancer.

    Published in:
    Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-0717-8
    By:
    • Sa, Jason K.;
    • Hong, Jung Yong;
    • Lee, In-Kyoung;
    • Kim, Ju-sun;
    • Sim, Moon-Hee;
    • Kim, Ha Jung;
    • An, Ji Yeong;
    • Sohn, Tae Sung;
    • Lee, Joon Ho;
    • Bae, Jae Moon;
    • Kim, Sung;
    • Kim, Kyoung-Mee;
    • Kim, Seung Tae;
    • Park, Se Hoon;
    • Park, Joon Oh;
    • Lim, Ho Yeong;
    • Kang, Won Ki;
    • Her, Nam-Gu;
    • Lee, Yeri;
    • Cho, Hee Jin
    Publication type:
    Article
    31
    32

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    33
    34

    First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920926796
    By:
    • Kim, Seung Tae;
    • Hong, Jung Yong;
    • Park, Se Hoon;
    • Park, Joon Oh;
    • Park, Young Whan;
    • Park, Neunggyu;
    • Lee, Hukeun;
    • Hong, Sung Hee;
    • Lee, Song-Jae;
    • Song, Seong-Won;
    • Kim, Kyung;
    • Park, Young Suk;
    • Lim, Ho Yeong;
    • Kang, Won Ki;
    • Nam, Do-Hyun;
    • Lee, Jeong-Won;
    • Park, Keunchil;
    • Kim, Kyoung-Mee;
    • Lee, Jeeyun
    Publication type:
    Article
    35
    36
    37
    38
    39

    Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2<sup>EV</sup> study.

    Published in:
    Clinical & Experimental Metastasis, 2025, v. 42, n. 2, p. 1, doi. 10.1007/s10585-025-10335-4
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Fujita, Kazutoshi;
    • de Liaño, Alfonso Gómez;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Yanagisawa, Takafumi;
    • Giannatempo, Patrizia;
    • Angel, Martin;
    • Mennitto, Alessia;
    • Molina-Cerrillo, Javier;
    • Bourlon, Maria T.;
    • Soares, Andrey;
    • Takeshita, Hideki;
    • Calabrò, Fabio;
    • Ortega, Cinzia;
    • Kucharz, Jakub;
    • Milella, Michele;
    • Seront, Emmanuel;
    • Park, Se Hoon
    Publication type:
    Article
    40
    41

    Safety and efficacy of single-agent docetaxel ( Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study.

    Published in:
    Thoracic Cancer, 2016, v. 7, n. 2, p. 207, doi. 10.1111/1759-7714.12315
    By:
    • Lim, Sun Min;
    • Park, Byeong Bae;
    • Park, Keun‐Chil;
    • Kim, Hoon‐Kyo;
    • Lee, Jong Seok;
    • Bae, Sung Hwa;
    • Lee, Seung‐Sei;
    • Kang, Jin‐Hyoung;
    • Park, Se‐Hoon;
    • Lee, Gyeong‐Won;
    • Lee, Hyo‐Rac;
    • Seo, Jae Hong;
    • Kim, Yong Tae;
    • Yang, Sung Hyun;
    • Kim, Joo‐Hang
    Publication type:
    Article
    42
    43

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    44
    45
    46

    Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1326, doi. 10.1002/ijc.35288
    By:
    • Grünwald, Viktor;
    • McKay, Rana R.;
    • Buchler, Tomas;
    • Eto, Masatoshi;
    • Park, Se Hoon;
    • Takagi, Toshio;
    • Zanetta, Sylvie;
    • Keizman, Daniel;
    • Suárez, Cristina;
    • Négrier, Sylvie;
    • Lee, Jae Lyun;
    • Santini, Daniele;
    • Bedke, Jens;
    • Staehler, Michael;
    • Kollmannsberger, Christian;
    • Choueiri, Toni K.;
    • Motzer, Robert J.;
    • Burgents, Joseph E.;
    • Xie, Ran;
    • Okpara, Chinyere E.
    Publication type:
    Article
    47

    Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 6, p. 1241, doi. 10.1002/ijc.34608
    By:
    • Rha, Sun Young;
    • Choueiri, Toni K.;
    • Matveev, Vsevolod B.;
    • Alyasova, Anna;
    • Hong, Sung‐Hoo;
    • Gordoa, Teresa Alonso;
    • Gurney, Howard;
    • Bjarnason, Georg A.;
    • Buchler, Tomas;
    • Pedrazzoli, Paolo;
    • Takagi, Toshio;
    • Park, Se Hoon;
    • Lee, Jae Lyun;
    • Perini, Rodolfo F.;
    • He, Cixin S.;
    • McKenzie, Jodi A.;
    • Eto, Masatoshi
    Publication type:
    Article
    48

    SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.

    Published in:
    Cancers, 2019, v. 11, n. 2, p. 187, doi. 10.3390/cancers11020187
    By:
    • van den Boorn, Héctor G.;
    • Abu-Hanna, Ameen;
    • ter Veer, Emil;
    • van Kleef, Jessy Joy;
    • Lordick, Florian;
    • Stahl, Michael;
    • Ajani, Jaffer A.;
    • Guimbaud, Rosine;
    • Park, Se Hoon;
    • Dutton, Susan J.;
    • Bang, Yung-Jue;
    • Boku, Narikazu;
    • Haj Mohammad, Nadia;
    • Sprangers, Mirjam A. G.;
    • Verhoeven, Rob H. A.;
    • Zwinderman, Aeilko H.;
    • van Oijen, Martijn G. H.;
    • van Laarhoven, Hanneke W. M.
    Publication type:
    Article
    49
    50